The Ministry of Health, Labor and Welfare has changed its policy regarding "antibody cocktail therapy" that can be used for mildly ill patients with the new coronavirus.
Initially, it was stated that some medical institutions would introduce it on a trial basis because of rare side effects, but after confirming that safety can be ensured, it will be approved for use in home visits nationwide. became.
"Antibody cocktail therapy," in which two drugs made of antibodies are administered by intravenous drip at the same time, was approved in July as the first therapeutic drug that can be used even in mildly ill patients.
Initially, it was intended only for inpatients, but since last month, it has been conditionally approved for outpatient use in addition to accommodation facilities.
In rare cases, serious symptoms such as fever and decreased oxygen saturation have been reported, so the Ministry of Health, Labor and Welfare introduced it on a trial basis at some medical institutions on the 16th. Above, he showed a policy to verify the issues.
However, on the 17th, it was decided to approve the use in home visits nationwide on the condition that it can be grasped even if the patient's condition deteriorates for 24 hours after administration.
It is said that it will be confirmed in advance whether the desired medical institution has a system to ensure the safety of patients.
The Ministry of Health, Labor and Welfare explains, "There is no change in the nation's stance of deciding whether or not to use it after carefully assessing whether safety can be ensured even during home visits."